Showing 161-170 of 2123 results for "".
Online Bonus: Opioid Dependence: Misperceptions Abound, but Physicians Can Help
https://practicalneurology.com/diseases-diagnoses/headache-pain/opioid-dependence-misperceptions-abound-but-physicians-can-help/30721/Moyamoya: An Update for the Practicing Neurologist
https://practicalneurology.com/diseases-diagnoses/stroke/moyamoya-an-update-for-the-practicing-neurologist/30306/Distinguishing between definite MMD, probable MMD, and MMS may not have significant practical implications.Movement Disorders Moment: Teleneurology for Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-teleneurology-for-movement-disorders/31694/Teleneurologic care for movement disorders can help address a care gap and may improve quality of life.An Update on the Management of Chronic Migraine
https://practicalneurology.com/diseases-diagnoses/headache-pain/an-update-on-the-management-of-chronic-migraine/30697/In 1672, Thomas Willis provided the first description of chronic migraine (CM) when he reported the case of the philosopher, Anne, Viscountess Conway, who was also treated by William Harvey and Robert Boyle without success.1-4 Has our treatment of chronic migraine since improved?Congenital Myasthenic Syndrome Treatment
https://practicalneurology.com/diseases-diagnoses/neuromuscular/congenital-myasthenic-syndrome-treatment/31555/Heterogeneity makes diagnosis and treatment challenging.Tenecteplase and the Future of Thrombolytics: A Practical Update for the Evolving Stroke Era
https://practicalneurology.com/diseases-diagnoses/stroke/tenecteplase-and-the-future-of-thrombolytics/49156/Tenecteplase is a practical alternative to alteplase for intravenous thrombolysis in acute ischemic stroke, offering pharmacologic and workflow advantages.Intracranial Atherosclerotic Disease
https://practicalneurology.com/diseases-diagnoses/stroke/intracranial-atherosclerotic-disease/30143/Neurologists need to be vigilant for this common cause of ischemic stroke, associated with the highest rates of recurrent stroke.Neuro-Oncology Outlook: Advancements in Targeted Molecular Therapy for Low-Grade Gliomas—Challenging the Treatment Paradigm
https://practicalneurology.com/diseases-diagnoses/imaging-testing/neuro-oncology-outlookbradvancements-in-targeted-molecular-therapy-for-low-grade-gliomas-challenging-the-treatment-paradigm/32121/Treatment with the IDH inhibitor vorasidenib increased median progression-free survival and time to next intervention in individuals with grade 2 gliomas under surveillance after surgical resection.Case Report: Cyclophosphamide as Rescue Agent in Myasthenic Crisis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/case-report-cyclophosphamide-as-rescue-agent-in-myasthenic-crisis/30120/When patients are refractory to first-line treatments for myasthenic crisis, cyclophosphamide may have benefits and warrants further study.Inpatient Management of Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/inpatient-management-of-parkinsons-disease/30619/As Parkinson's patients advance through their disease, they are hospitalized more frequently than their age-matched controls.